Tibet Aim Pharm Inc (002826) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.109x

Based on the latest financial reports, Tibet Aim Pharm Inc (002826) has a cash flow conversion efficiency ratio of 0.109x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥87.55 Million ≈ $12.81 Million USD) by net assets (CN¥802.15 Million ≈ $117.38 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Tibet Aim Pharm Inc worth for the company's overall valuation and market capitalisation.

Tibet Aim Pharm Inc - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Tibet Aim Pharm Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Tibet Aim Pharm Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tibet Aim Pharm Inc ranked by their cash flow conversion efficiency. Explore Tibet Aim Pharm Inc (002826) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
SNT Dynamics Co Ltd KO:003570	-0.051x
Shengtak New Material Co Ltd SHE:300881	-0.093x
Shenzhen RoadRover Technology Co Ltd SHE:002813	-0.077x
Kforce Inc. NYSE:KFRC	0.158x
Beijing Hanyi Innovation Technology Co. Ltd. A SHE:301270	N/A
Topkey Corp TW:4536	0.026x
Clientele JSE:CLI	-0.059x
Cantor Equity Partners IV, Inc. Class A Ordinary Shares NASDAQ:CEPF	0.000x

Annual Cash Flow Conversion Efficiency for Tibet Aim Pharm Inc (2013–2025)

The table below shows the annual cash flow conversion efficiency of Tibet Aim Pharm Inc from 2013 to 2025. View Tibet Aim Pharm Inc share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥816.02 Million ≈ $119.41 Million	CN¥123.72 Million ≈ $18.10 Million	0.152x	+1.31%
2024-12-31	CN¥745.58 Million ≈ $109.10 Million	CN¥111.57 Million ≈ $16.33 Million	0.150x	-32.74%
2023-12-31	CN¥750.06 Million ≈ $109.76 Million	CN¥166.88 Million ≈ $24.42 Million	0.222x	+143.77%
2022-12-31	CN¥750.00 Million ≈ $109.75 Million	CN¥68.45 Million ≈ $10.02 Million	0.091x	-39.99%
2021-12-31	CN¥720.11 Million ≈ $105.37 Million	CN¥109.52 Million ≈ $16.03 Million	0.152x	+2.73%
2020-12-31	CN¥687.15 Million ≈ $100.55 Million	CN¥101.74 Million ≈ $14.89 Million	0.148x	+63.10%
2019-12-31	CN¥652.17 Million ≈ $95.43 Million	CN¥59.20 Million ≈ $8.66 Million	0.091x	+321.64%
2018-12-31	CN¥618.40 Million ≈ $90.49 Million	CN¥13.31 Million ≈ $1.95 Million	0.022x	-83.16%
2017-12-31	CN¥604.53 Million ≈ $88.46 Million	CN¥77.29 Million ≈ $11.31 Million	0.128x	+24.19%
2016-12-31	CN¥555.44 Million ≈ $81.28 Million	CN¥57.18 Million ≈ $8.37 Million	0.103x	+186.07%
2015-12-31	CN¥248.25 Million ≈ $36.33 Million	CN¥-29.69 Million ≈ $-4.34 Million	-0.120x	-1080.84%
2014-12-31	CN¥179.12 Million ≈ $26.21 Million	CN¥2.18 Million ≈ $319.61K	0.012x	-98.33%
2013-12-31	CN¥71.66 Million ≈ $10.49 Million	CN¥52.24 Million ≈ $7.64 Million	0.729x	--

About Tibet Aim Pharm Inc

SHE:002826 China Drug Manufacturers - Specialty & Generic

Market Cap

$475.17 Million

CN¥3.25 Billion CNY

Market Cap Rank

#12630 Global

#3708 in China

Share Price

CN¥17.03

Change (1 day)

+0.12%

52-Week Range

CN¥15.01 - CN¥22.24

All Time High

CN¥32.76